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Residential and agricultural pesticide use is
widespread in the United States, with approx-
imately one billion pounds of pesticides used
annually. Recent studies have demonstrated
widespread pesticide exposure to the U.S.
population, including pregnant women and
children (Berkowitz et al. 2003; Hill et al.
1989, 1995; Kutz et al. 1992; Lu et al. 2001;
National Center for Environmental Health
2001; Whyatt et al. 2002). Overall, these
studies confirm that children are exposed to
pesticides prenatally, when they may be par-
ticularly vulnerable to adverse health effects
(Eskenazi et al. 1999).
Measurements of pesticides and other
chemicals in meconium and amniotic fluid,
which are produced by the fetus, are likely to
be useful biomarkers of direct fetal exposure.
Chemicals in these media may represent
cumulative exposures derived from ongoing
and/or transient maternal exposures to chemi-
cals that have short half-lives in the body, such
as organophosphate (OP) pesticides (Bearer et
al. 1999; Foster et al. 2000; Hong et al. 2002;
Ostrea et al. 1993, 2002; Whyatt and Barr
2001). Although meconium is likely to repre-
sent exposures from the second trimester
through delivery (Bearer et al. 1999; Hong et
al. 2002; Ostrea et al. 1993, 2002; Whyatt and
Barr 2001), amniotic fluid, collected during
amniocentesis, is the only biologic medium
available that can be used to characterize early
fetal exposures (~15–20 weeks).
Amniotic ﬂuid surrounds and protects the
developing embryo and fetus. It is present
soon after implantation and increases in
volume throughout pregnancy (Hytten and
Chamberlain 1991). The composition of
amniotic ﬂuid, which is primarily fetal urine,
varies over the course of gestation, reﬂecting
the sequential maturation of fetal organs and
accompanying shifts in sites of fetal metabo-
lism and filtration. Although the fetal lungs
and kidneys excrete ﬂuid continuously into the
amniotic ﬂuid reservoir, the fetus is also con-
tinuously swallowing and “inhaling” amniotic
ﬂuid. This cycling suggests that toxic substances
excreted into the amniotic ﬂuid may continu-
ously reexpose the fetus. Although the placenta
prevents the transfer of some toxicants from the
mother to fetus, many chemicals can cross this
barrier (McMichael et al. 1986; Moore et al.
1982; O’Leary et al. 1970; Talbot et al. 1988).
Additionally, paraplacental transfer, where toxi-
cants transfer directly from maternal blood
through the amniotic sac, can also contaminate
amniotic ﬂuid (Schmidt 1992).
Studies of organochlorine compounds
[including dichlorodiphenyldichloroethylene
(DDE) and dichlorodiphenyltrichloroethane
(DDT)], therapeutic and illegal drugs, ﬁrst-hand
and environmental tobacco smoke, dust mite
allergens, and metals indicate that toxicants are
detectable in amniotic ﬂuid and are likely to
reflect fetal exposures (Carvalho et al. 2001;
Foster et al. 2000; Holloway et al. 2000;
Jauniaux et al. 1999; Kim et al. 1998; O’Leary
et al. 1970; Polishuk et al. 1977; Talbot et al.
1988; Winecker et al. 1997). To date, no studies
have investigated levels of common nonpersis-
tent pesticides in amniotic ﬂuid. In the present
study, we determined whether analytical proce-
dures for measuring nonspeciﬁc OP pesticide
metabolites (dialkyl phosphates), OP-speciﬁc
metabolites, pyrethroid pesticide metabolites,
and pesticides with chlorinated phenol metabo-
lites in urine were transferable to amniotic ﬂuid,
and we report concentration data for several of
these analytes.
Materials and Methods
Population. Amniotic fluid samples were
collected from 100 women referred to the
Children’s Hospital Central California in
Madera, California, which serves a cross sec-
tion of California residents living in the San
Joaquin Valley. The San Joaquin Valley is an
agricultural area that also includes several
urban centers, including the Madera–Fresno
metropolitan area. The 100 samples collected
represent a convenience sample. All women
were referred for amniocentesis because of an
elevated risk for genetic disorders, such as
advanced maternal age, family history of
genetic disease, and abnormalities on serum
screening. Medical records were abstracted
from a subset of women (n = 50), selected
randomly, for basic demographic and health
information. This study was approved by the
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Prenatal pesticide exposures may adversely affect children’s health. However, exposure and health
research is hampered by the lack of reliable fetal exposure data. No studies have been published that
report measurements of commonly used nonpersistent pesticides in human amniotic fluid,
although recent studies of pesticides in urine from pregnant women and in meconium indicate that
fetuses are exposed to these chemicals. Amniotic ﬂuid collected during amniocentesis is the only
medium available to characterize direct fetal exposures early in pregnancy (~18 weeks of gestation).
As a ﬁrst step in validating this exposure biomarker, we collected 100 amniotic ﬂuid samples slated
for disposal and evaluated analytical methods to measure organophosphate and carbamate pesti-
cides and metabolites, synthetic pyrethroid metabolites, herbicides, and chlorinated phenolic com-
pounds. The following six phenols were detected (detection frequency): 1- and 2-naphthol (70%),
2,5-dichlorophenol (55%), carbofuranphenol (5%), ortho-phenylphenol (30%), and penta-
chlorophenol (15%), with geometric mean concentrations of 0.72, 0.39, 0.12, 0.13, and 0.23 µg/L,
respectively, for positive values. The organophosphate metabolites diethylphosphate and
dimethylphosphate were detected in two (10%) samples, and dimethylthiophosphate was detected
in one (5%) sample, with geometric mean concentrations of 0.31, 0.32, and 0.43 µg/L, respec-
tively, for positive values. These levels are low compared with levels reported in urine, blood, and
meconium in other studies, but indicate direct exposures to the young fetus, possibly during critical
periods of development. Results of this pilot study suggest that amniotic fluid offers a unique
opportunity to investigate fetal exposures and health risks. Key words: amniotic fluid, exposure,
fetus, pesticides. Environ Health Perspect 111:1779–1782 (2003). doi:10.1289/ehp.6259 available
via http://dx.doi.org/ [Online 7 August 2003]
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Committee for the Protection of Human
Subjects and the Children’s Hospital Central
California Institutional Review Board.
Sample collection method. Medical staff
collected 15–20 mL of amniotic ﬂuid accord-
ing to standard clinical procedures for amnio-
centesis, which were then centrifuged. Cells
were removed for cytogenetic analysis, and
2 mL were aliquotted for laboratory tests.
According to California State requirements,
4 mL of ﬂuid were stored at –80°C for at least
30 days in case the clinical or laboratory tests
were positive or inconclusive and required fol-
low-up testing. After 30 days, these 4-mL
samples are normally discarded. We selected
100 of these samples that were slated for dis-
posal. Samples were bar coded and shipped
on dry ice to the Centers for Disease Control
and Prevention (CDC; Atlanta, GA), where
they were stored at –80°C until analysis.
Before collection and analysis, all clinical and
laboratory equipment, including syringe com-
ponents, centrifuge containers, and storage
vials, were evaluated by the CDC for poten-
tial interferences that could adversely affect
laboratory analyses.
Chemical analysis method. Of the 100 
4-ml samples, 20 were pooled for method
validation and laboratory quality assurance
and control. The remaining 80 samples were
divided into four sets of 20 and analyzed by
four separate mass spectrometry–based meth-
ods to measure a) synthetic pyrethroids,
b) chemical-speciﬁc metabolites of OP pesti-
cides, c) class-speciﬁc metabolites of OP pesti-
cides, and d) pesticides, including carbamates,
herbicides, and pesticides with chlorinated
phenol metabolites, such as disinfectants.
These target analytes and their respective
detection limits are listed in Tables 1 and 2.
Laboratory methods involved a solid-phase or
liquid partitioning extraction with analysis
using tandem mass spectrometry and isotope
dilution gas chromatography–mass spectrom-
etry/mass spectrometry methods previously
developed by the CDC for urine. Detailed
descriptions of these analytical procedures are
presented elsewhere (Baker et al. 2000; Barr
et al. 1999; Beeson et al. 1999; Bravo et al.
2002; Shealy et al. 1996; Whyatt and Barr
2001). Because amniotic fluid is similar to
urine, no major modifications in method-
ology were required, although minor changes
were necessary (described in “Results”).
Laboratory quality assurance included repeat
analysis of spiked matrix pools (10 µg/L of
each analyte) and inclusion of these spiked
pools in each run. Results from these samples
provided data on recovery and precision. An
analytical run was considered “out of control”
if a) either of the two quality control (QC) val-
ues was outside the 99th percentile conﬁdence
limits (mean + 3 SD); b) both QC values were
outside of the 95th percentile conﬁdence limits
(mean + 2 SD) even if on opposite sides of the
mean; c) one QC value was outside the 95th
percentile conﬁdence intervals and the preced-
ing nine measurements were on the same side
of the mean (www.westgard.com). Data were
not reported from runs considered “out of
control.” To determine the stability of ana-
lytes in amniotic fluid, aliquots of amniotic
fluid were kept either at room temperature,
under refrigeration, or frozen for 0–12 hr and
analyzed every hour.
Results
Population characteristics. For the subset of 50
women with demographic and medical informa-
tion, the mean age was 34.4 ± 6.1 years, with a
range of 18–43 years. The mean gestational age
was 18 ± 2.6 weeks. White women comprised
44% of the sample; the remaining 56% were of
unspeciﬁed ethnicity. Reasons for referral for
amniocentesis included advanced maternal age
(72%), positive screen for Down syndrome
(14%), a positive serum-extended α-fetoprotein
test (6%), abnormal ultrasound (6%), and
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Table 1. Concentrations of chemicals detected in amniotic ﬂuid (µg/L) and laboratory parameters for amniotic
ﬂuid compared with historical results for urine.a
Amniotic ﬂuid Historical urine results
Detects Mean recovery Mean recovery
Analyte [n (%)] GM Min Max LOD ± CV (%)b LOD ± CV (%)c
1- or 2-Naphthol 14 (70) 0.72 0.61 4.19 0.10 98 ± 4 0.20, 0.40d 96 ± 2
2,5-Dichlorophenol 11 (55) 0.39 0.37 0.43 0.10 91 ± 7 0.10 93 ± 3
Carbofuranphenol 1 (5) 0.12 0.12 0.12 0.10 81 ± 4 0.20 92 ± 5
o-Phenylphenol 6 (30) 0.13 0.10 0.17 0.10 91 ± 4 0.30 93 ± 2
Pentachlorophenol 3 (15) 0.23 0.15 0.54 0.10 68 ± 4 0.50 64 ± 3
DEP 2 (10) 0.31 0.26 0.36 0.20 81 ± 9 0.20 85 ± 8
DMP 2 (10) 0.32 0.30 0.34 0.20 85 ± 22 0.50 90 ± 20
DMTP 1 (5) 0.43 0.43 0.43 0.20 92 ± 8 0.50 99 ± 7
Abbreviations: CV, coefﬁcient of variability; GM, geometric mean; max, maximum; min, minimum.
aHistorical results for CDC method development projects (Barr D. Personal communication). bn = 5 spike samples; extraction
recovery is based on spike at 10 µg/L for amniotic ﬂuid. cn ≤ 25 samples; urine spiking level varied from 2.5 to 20 µg/L. dLevels
of detection provided for 1-naphthol and 2-naphthol, respectively, in urine.
Table 2. Levels of detection (µg/L) and laboratory recovery for analytes not detected in amniotic ﬂuid com-
pared with historical laboratory results for urine.a
Amniotic ﬂuid Urine
Mean recovery Mean recovery
Analyte LOD ± CV (%)b LOD ± CV (%)c
2-Isopropoxyphenol 0.10 86 ± 12 1.10 84 ± 9
2,4-Dichlorophenol 0.10 86 ± 4 0.30 94 ± 3
2,4,5-Trichlorophenol 0.10 82 ± 6 0.90 80 ± 2
2,4,6-Trichlorophenol 0.10 83 ± 6 1.30 91 ± 6
3,5,6-Trichloro-2-pyridinol 0.10 98 ± 4 0.40 101 ± 4
4-Nitrophenol 0.10 91 ± 2 0.10 94 ± 2
Acephate 1 35 ± 6 0.80 34 ± 8
3-Chloro-4-methyl-7-hydroxycoumarin 1 90 ± 2 0.20 91 ± 3
Diethyldithiophosphate 0.20 91 ± 6 0.10 89 ± 7
Diethylthiophosphate 0.20 91 ± 6 0.20 89 ± 5
Dimethyldithiophosphate 0.20 96 ± 2 0.10 98 ± 4
Methyl-1,2,3-benzotriazin-4-one 1 86 ± 4 6 90 ± 7
5-Chloro-1,2-dihydro-1-isopropyl-[3H]-1,2,4-triazol-3-one 1 86 ± 3 1 88 ± 6
Methamidaphos 1 21 ± 10 0.2 21 ± 13
2-Diethylamino-6-methyl pyrimidin-4-ol 1 92 ± 3 0.2 98 ± 3
3-Phenoxybenzoic acid 0.80 78 ± 6 0.1 77 ± 10
4-Fluoro-3-phenoxybenzoic acid 0.50 78 ± 6 0.3 79 ± 6
cis-DBCA 0.30 90 ± 3 0.2 88 ± 10
cis-DCCA 0.20 90 ± 6 0.5 91 ± 12
trans-DCCA 0.40 91 ± 6 0.5 93 ± 7
2-Isopropyl-4-methyl-6-hydroxypyrimidine 0.04 93 ± 4 0.2 93 ± 3
2,4-Dichlorophenoxyacetic acid 0.50 95 ± 8 0.2 96 ± 9
2,4,5-Trichlorophenoxyacetic acid 0.50 91 ± 10 0.1 93 ± 7
3-Phenoxybenzoic acid 1 76 ± 5 0.1 72 ± 6
Acetochlor mercapturate 0.5 93 ± 5 0.1 97 ± 4
Alachlor mercapturate 10 Not determined 3 95 ± 6
Atrazine mercapturate 0.60 97 ± 6 0.1 99 ± 5
Diethyltoluamide 0.40 100 ± 3 0.1 98 ± 4
Malathion diacid 0.60 75 ± 8 0.3 78 ± 5
Metolachlor mercapturate 0.90 90 ± 7 0.2 91 ± 9
Abbreviations: cis-DBCA, cis-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropane-1-carboxylic acid; cis-DCCA, cis-3-(2,2-
dichlorovinyl)-2,2-dimethylcyclopropane-1-carboxylic acid; CV, coefficient of variability; trans-DCCA, trans-3-(2,2-
dichlorovinyl)-2,2-dimethylcyclopropane-1-carboxylic acid.
aHistorical results for CDC method development projects (Barr D. Personal communication). bn = 5 spike samples; extraction
recovery is based on spike at 10 µg/L for amniotic ﬂuid. cn ≤ 25 samples; urine spiking level varied from 2.5 to 20 µg/L.chromosomal or other abnormalities (22%)
(total sums to > 100% because of multiple
indicators for some women).
Laboratory analysis. Tables 1 and 2 pre-
sent the limits of detection (LODs) and percent
recovery for repeat analysis of spiked amniotic
fluid samples and historical results for urine
from CDC method development projects.
Mean recovery of spiked analytes in amniotic
fluid ranged from 21% to 100% and were
almost identical to historical results for urine.
Mean recoveries were below 75% for only three
analytes (pentachlorophenol, acephate, and
methamidophos; Tables 1 and 2). Precision of
repeat measurements were consistent with his-
torical results for urine, with the average coefﬁ-
cient of variability (CV) equal to 8%, and only
eight samples with CVs greater than 8%. LODs
for the amniotic fluid measurements were
also similar to historical results for urine (Tables
1 and 2). Interferences not present in ordinary
urine initially reduced sensitivity of detection
methods for OPs; however, adjustment of
ion monitoring parameters mitigated these
problems. Most analytes were stable in spiked
amniotic fluid at ambient temperature and
refrigeration for 12 hr, and all analytes were sta-
ble at –20°C for more than 2 weeks. Calculated
concentrations were similar to spiked concen-
trations (Figure 1). Slopes of the amniotic
ﬂuid–spiked calibration plots were linear (Figure
2) and were similar to those of neat standards.
Table 1 presents results for the chemicals
detected in amniotic fluid. Five compounds
were detected in the chlorinated phenols
assay. Eighteen (90%) samples had detectable
levels of at least one chlorinated pesticide,
with concentrations ranging from 0.10 to
4.19 µg/L. Five of 20 samples (25%) in the
nonspeciﬁc OP pesticide metabolite assay had
detectable levels of diethylphosphate (DEP),
dimethylphosphate (DMP), or dimethylthio-
phosphate (DMTP), with concentrations
ranging from 0.26 to 0.43 µg/L.
No chemicals analyzed in the pyrethroid
or chemical-speciﬁc OP assays were detected
(see Table 2).
Discussion
Laboratory methods for measuring pesticides
and other toxicants in urine were transferable
to amniotic fluid with minor modifications.
Detection limits, precision, and analytical
recovery were similar to urine methods (Baker
et al. 2000; Barr et al. 1999; Beeson et al.
1999; Bravo et al. 2002; Shealy et al. 1996).
Metabolites derived from naphthalene, car-
baryl, para-dichlorobenzene, ortho-phenyl-
phenol, carbofuran, pentachlorophenol, and
OP pesticides were detected in this small sam-
ple of amniotic ﬂuid samples, indicating that
fetal exposures to these compounds occur as
early as 15–18 weeks gestation, possibly during
sensitive developmental periods.
The presence of these metabolites may
reflect exposures to common ingredients of
consumer products. For example, naphthalene
and para-dichlorobenzene are used in various
moth repellents as well as in toilet and diaper
pail deodorizers (Sciences International Inc.
2002). ortho-Phenylphenol is a common indus-
trial disinfectant and is used as a postharvest
food preservative on citrus fruits and vegetables
(OEHHA 2000). Carbofuran, a carbamate pes-
ticide, and the OP metabolites derive from
cholinesterase-inhibiting pesticides used in
agriculture. Potential exposure sources include
residues in the diet (U.S. Department of
Agriculture 2000) and home or agricultural
pesticide use (Bradman et al. 1997; Curl et al.
2002; Fenske et al. 2002; Lu et al. 2000; Simcox
et al. 1995). Pentachlorophenol, a wood preser-
vative that is now banned, is still widely dis-
persed in the environment. Both carbaryl and
naphthalene are sources of the 1-naphthol
metabolite. Naphthalene is also metabolized to
2-naphthol. Levels of 1- and 2-naphthol are
usually correlated when they are both derived
from naphthalene (Hill et al. 1995; Shealy et al.
1997). In our study, however, only one sample
had detectable levels of 2-naphthol, whereas 
1-naphthol was detected in 13 other samples.
Because 1- and 2-naphthol levels are not corre-
lated in this study, it is possible that carbaryl
may have been an additional source of 1-naph-
thol (Shealy et al. 1997).
The levels of the chemicals detected in our
study were lower compared with previously
reported levels in meconium, urine, and blood.
For example, Whyatt and Barr (2001) detected
DEP and diethylthiophosphate in 95 and 100%
of 20 meconium samples, respectively, with
ranges of 800–5,600 µg/L, whereas diethyl-
dithiophosphate and DMP were detected in
only 1 of 20 meconium samples at 1,800 and
16,000 µg/L, respectively. Hill et al. (1989)
reported median levels (and detection frequen-
cies) of pentachlorophenol and 2,5-dichloro-
phenol of 14 µg/L (100%) and 9 µg/L (96%),
respectively, in urine samples from children
2–6 years of age living near a herbicide manu-
facturing plant. In a study of U.S. residents
without known sources of pentachlorophenol
exposure, Cline et al. (1989) reported a median
level in urine of 3 µg/L and 40 µg/L in blood.
Finally, for U.S. children 6–11 years of age,
median levels of DEP, DMP, and DMTP were
1.4, 1.0, and 4.1 µg/L, and 1-naphthol, 
2,5-dichlorophenol, and ortho-phenylphenol
levels were 1.1, 9.0, and 0.49 µg/L (National
Center for Environmental Health 2003).
Because of the small sample size (n = 20 for
each analysis), it is not possible to generalize
our ﬁndings to other populations. Pyrethroid
pesticide metabolites were not detected in any
samples, although they are used widely in
homes (Landrigan et al. 1999). Similarly, none
of the herbicides, including atrazine, alachlor,
and acetachlor, were detected in the amniotic
ﬂuid samples. These chemicals may not have
been detected for several reasons: a) The LODs
may have been too high, b) the toxicant may
not cross the maternal–fetal barrier, or c) no
exposure to the mother may have occurred. It
is possible that these compounds would be
detected in larger volumes of amniotic ﬂuid,
in larger surveys, in women with pesticide
exposure risk factors or in different geographic
areas. Additionally, future studies are likely to
beneﬁt from technical improvements in labo-
ratory analysis methods, resulting in lower
detection limits.
Because of risks to the fetus, amniocentesis
is conducted only when there is an elevated
Children’s Health | Pesticides in amniotic fluid
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Figure 1. Linear regression analyses of plots of the
calculated concentrations versus the spiked con-
centrations for (A) the phenolic analytes (y = 0.9965x
– 0.0243; R2 = 0.9989) and (B) the dialkylphosphate
analytes (y = x – 6 × 10–15; R2 = 0.9966) yielded slopes
that were within 1% of 1.0, indicating the analytical
methods were highly accurate.
01 02 0 3 04 0 5 0 6 0
01 02 0 3 04 0 5 0 6 0
60
50
40
30
20
10
0
60
50
40
30
20
10
0
S
p
i
k
e
d
c
o
n
c
e
n
t
r
a
t
i
o
n
s
 
(
µ
g
/
L
)
S
p
i
k
e
d
c
o
n
c
e
n
t
r
a
t
i
o
n
s
 
(
µ
g
/
L
)
Calculated concentration (µg/L)
◆ ◆ ◆
◆ ◆
◆ ◆ ◆ ◆
◆ ◆
◆ ◆ ◆ ◆ ◆
◆ ◆ ◆ ◆
◆
◆ ◆ ◆
◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆ ◆
A
B
Figure 2. Calibration plots of (A) 3,5,6-trichloro-
pyridinol (R2 = 0.9985), (B) 2,5-dichlorophenol (R2 =
0.9998), and (C) DMP (R2 = 0.9979) were very linear
with < 2.3% error about their respective slopes.
ISTD, internal standard. Similar plots were obtained
for the other chemicals measured.
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◆ ◆ ◆ ◆risk of congenital defects. Therefore, the pop-
ulation sampled will always be biased and can-
not represent the total population of pregnant
women. For women already undergoing the
procedure, collection of the amniotic ﬂuid for
research purposes is noninvasive. Given that
many women receive amniocenteses annually
(> 40,000 in California alone; Goldman S.
Personal communication), a large source of
material is safely available for testing to estab-
lish background levels of pesticides and other
toxicants in amniotic fluid and to identify
sources of fetal exposures. Amniotic ﬂuid can
also be collected at delivery. Thus, it may also
be possible to conduct exposure and health
studies that are representative of the general
population. Studies using amniotic ﬂuid col-
lected at delivery, however, would not allow
distinction between exposures early and late in
gestation.
This study is a ﬁrst step toward validating
measurements of nonpersistent pesticides in
amniotic ﬂuid as an exposure biomarker. Next
steps should include larger surveys that include
women from diverse geographic areas and
who have potential pesticide exposure risk fac-
tors to deﬁne which chemicals are present in
this medium. Additional studies that measure
nonpersistent pesticides in amniotic ﬂuid and
concurrently sampled maternal blood and
urine samples would also provide data on the
interrelationships of maternal and fetal expo-
sures and aid in the development of physiolog-
ically based pharmacokinetic (PBPK) models
for pregnant women and fetuses. Several
researchers are currently developing PBPK
models describing toxicant dynamics during
pregnancy (Luecke et al. 1994, 1997a, 1997b;
Young 1998; Young et al. 1997), which may
become valuable tools for estimating fetal
exposures for risk assessment or epidemiologic
studies investigating prenatal exposures where
only maternal biologic samples are available.
Given the initial promising findings of this
study, additional research is needed to better
characterize contaminants in amniotic fluid
and the potential health risks to the fetus and
developing child.
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